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Introduction
The rapid diffusion of carbapenem-resistant (C-R)
Klebsiella pneumoniae (Kp) represents a global concern
from both clinical and public health standpoints. In parti-
cular, bloodstream infections sustained by C-R Kp are
associated with high mortality rates and the treatment of
these clinical picture is a major challenge for clinicians.
Objectives
To describe annual incidence of C-R Kp BSI, dating
back to the first positive C-R Kp blood culture, in a
1,300-beds teaching hospital in northern Italy.
Methods
We performed a retrospective study at IRCCS AOU San
Martino – IST of Genoa, Italy. Between 1 January 2007
and 31 December 2014, overall hospitalizations and hos-
pital patient-days were obtained from the hospital digital
archives of patients’ clinical charts. Similarly, numbers of
C-R Kp BSI were identified through the computerized
microbiology laboratory database. Annual incidences of
health-care associated C-R Kp BSI per 10,000 patient-
days were calculated. Overall trends in the incidence of
Kp BSI were recorded, by including annual incidences
of carbapenem-susceptible (C-S) Kp BSI. Finally, 30-day
survivals of both C-R and C-S Kp BSI were estimated.
Results
From 2007 to 2014, we identified 511 episodes of Kp
BSI, 349 of which caused by C-R Kp (68.3%). The over-
all incidence of C-R Kp BSI during the seven-year study
period was 0.92/10,000 patient-days, with a peak of
1.77/10,000 patient-days in 2014. The highest annual
incidences were registered in intensive care units, with a
peak of 22.01 C-R Kp BSI/10,000 patient-days in 2012.
The annual incidence of C-S Kp BSI remained steady
throughout the study period. 30-day survival was signifi-
cantly lower in C-R patients than C-S patients (Log-
rank p = 0.002).
Conclusion
In our hospital we observed a dramatic increase in the
incidence of C-R Kp BSI occurred from 2009 to 2014.
More efforts might be necessary to tackle the worrying
C-R Kp diffusion in our hospital. Because of the dra-
matic shortage in antibiotics active against C-R Kp,
further improvements in our infection-control practises
are also of paramount importance to limit the high
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